Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Chronic hepatitis C therapy: A rare complication revisited
Mohammed E yad Yaseen Alsabbagh
, Naseem Eisa
, Abdul H amid Alraiyes
, M. Chadi Alraies
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chronic hepatitis C therapy: A rare complication revisited'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Hepatitis C
100%
Hepatitis C Treatment
100%
Hepatitis C Virus Infection
100%
Rare Complication
100%
Older Men
50%
Effective Therapy
50%
Ribavirin
50%
Disease Course
50%
Protease Inhibitors
50%
50 Years Old
50%
Peginterferon
50%
Boceprevir
50%
Telaprevir
50%
Rare Side Effect
50%
Insulin-dependent Diabetes
50%
Combined Therapy
50%
Combined Regimen
50%
Portents
50%
Medicine and Dentistry
Hepatitis C
100%
Chronic Hepatitis C
100%
Infection
66%
Side Effect
66%
Insulin Dependent Diabetes Mellitus
33%
Combined Therapy
33%
Proteinase Inhibitor
33%
Ribavirin
33%
Peginterferon
33%
Telaprevir
33%
Boceprevir
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis C
100%
Hepatitis C
100%
Infection
66%
Side Effect
66%
Insulin Dependent Diabetes Mellitus
33%
Ribavirin
33%
Peginterferon
33%
Proteinase Inhibitor
33%
Boceprevir
33%
Telaprevir
33%
Diseases
33%